← signals
2026-07-21·INTC·partnership
medup

A prediction market on Manifold shows 96.54% consensus that Tesla will announce a formal partnership with Intel for AI...

A prediction market on Manifold shows 96.54% consensus that Tesla will announce a formal partnership with Intel for AI chip fabrication by June 30, 2026 (source: This would be a major win for Intel's foundry services, potentially bringing in a high-volume customer like Tesla for AI chips. The high probability suggests significant insider knowledge or public signals. Intel has been ramping its foundry capabilities, and a Tesla partnership would validate its progress. What the sources said: - Manifold market description: 'Tesla announces formal Intel partnership for AI chip fab by June 30, 2026' with current probability 96.54%.

window 30devidence 4confidence score 71price INTC $96.98

confidence score

Usable evidence: enough corroboration to publish, with 1 independent source class.

71
medium confidence1 independent source classesmarketmedium high without independent sourcespasses publish gate
priced-in check

INTC has already moved up +42% over the recent 30-90 day window.

partly priced
as of 2026-07-167d n/a45d n/a90d +42%yahoo

signal brief

A prediction market on Manifold shows 96.54% consensus that Tesla will announce a formal partnership with Intel for AI chip fabrication by June 30, 2026 (source: https://manifold.markets/ChristophUSOtz/tesla-announces-formal-intel-partne...). This would be a major win for Intel's foundry services, potentially bringing in a high-volume customer like Tesla for AI chips. The high probability suggests significant insider knowledge or public signals. Intel has been ramping its foundry capabilities, and a Tesla partnership would validate its progress.

What the sources said:

  • Manifold market description: 'Tesla announces formal Intel partnership for AI chip fab by June 30, 2026' with current probability 96.54%.

source data used

spillover entities

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.